Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

Jemma L. O’Connor(University College London), Russell J. Everett(Edinburgh Royal Infirmary), Sris Allan(Coventry and Warwickshire Partnership NHS Trust), David Dunn(Indiana University – Purdue University Indianapolis), Colette Smith(MRC Clinical Trials Unit at UCL), Nicky Perry(University College London), Chloe Orkin(Queen Mary University of London), Alan Winston, Mark Gompels, Deenan Pillay(University College London), Stephen Kegg(South London Healthcare NHS Trust), John Walsh(Krirk University), Jane Anderson(Baylor College of Medicine), Jillian Pritchard, Fiona Lampe(University College London), Valérie Delpech(Animal and Plant Health Agency), Martin Fisher(Northwell Health), Stuart Tilbury, Sophie José(NHS England), Frank A. Post(King's College Hospital NHS Foundation Trust), Fabiola Martin(Institut de Recerca Biomèdica Catalunya Sud), Achim Schwenk(Roland Hill (United Kingdom)), Roy Trevelion, Clifford Leen, Richard Gilson(University College London), Adrian Palfreeman(University of Leicester), Adam Glabay, Caroline Sabin(Primary Health Care), Memory Sachikonye, Margaret Johnson(Duke University), Phillip Hay(Northwick Park Hospital), Mark Nelson(University of Tasmania), Teresa Hill, David R. Chadwick(James Cook University Hospital), Abdel Babiker(MRC Clinical Trials Unit at UCL), Jonathan Ainsworth, Brian Gazzard(British HIV Association), Duncan Churchill, Anjum Tariq(The Royal Wolverhampton NHS Trust), Elaney Youssef(Roland Hill (United Kingdom)), David Chadwick(Lancaster University), Andrew Phillips(Wake Forest University)
The Lancet HIV
May 4, 2017
Cited by 67


Related Papers